IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic
An, Shu-Chang1; Xu, Li-Li2,3,4; Li, Feng-Di2,3,4; Bao, Lin-Lin2,3,4; Qin, Chuan2,3,4; Gao, Zhan-Cheng1
刊名MEDICAL HYPOTHESES
2011-12-01
DOI10.1016/j.mehy.2011.09.001
77期:6页:1054-1057
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, Research & Experimental
研究领域[WOS]Research & Experimental Medicine
关键词[WOS]A H5N1 INFECTION ; TRANSCRIPTION FACTORS ; VIRUS-INFECTION ; INFLAMMATION ; CELLS ; HMG-1 ; LIPOPOLYSACCHARIDE ; FENOFIBRATE ; EXPRESSION ; RESISTANCE
英文摘要

The high mortality of highly pathogenic avian influenza A (H5N1) viruses infection in humans gives rise to considerable concern that it might someday cause another lethal pandemic. At present there is no other effective alternative besides the early and enough administration of neuraminidase inhibitors, which may be crucial for the patient management. However, its efficacy is sometimes limited because of the late administration in some patients especially the seriously ill ones and the continual occurrence of oseltamivir resistant A (H5N1) strains. The specific candidate vaccine are still under development and the practical value of passive immunization is hard to be widely applied because of the scarcity of convalescent human plasma, especially in the early stage of a serious and rapidly progressing pandemic. Statins and fibrates, both of which are used in clinical practice, have anti-inflammatory and immunomodulatory effects and other multiple biologic activities. So we hypothesized that the two immunomodulatory agents may exhibit synergistic effects when they were combined to neuraminidase inhibitors to treat the A (H5N1) viruses infections via inhibiting the production of either the early inflammatory mediators (e.g., many cytokine/chemokine) or the late mediator (e.g., High Mobility Group Box Protein 1), even showing the anti-viral activities with the prevention of the development of antiviral resistance. Therefore, the novel triple combinations may be an optimal management to confront the next lethal influenza pandemic on its very beginning. (C) 2011 Elsevier Ltd. All rights reserved.

语种英语
WOS记录号WOS:000297400600031
项目编号2009ZX10004-016
资助机构Ministry of Science and Technology of China
引用统计
被引频次:10[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60708
专题北京大学第二临床医学院
北京大学第二临床医学院_呼吸科
作者单位1.Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100044, Peoples R China
2.Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China
3.PUMC, Comparat Med Ctr, Beijing 100021, Peoples R China
4.Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China
推荐引用方式
GB/T 7714
An, Shu-Chang,Xu, Li-Li,Li, Feng-Di,et al. Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic[J]. MEDICAL HYPOTHESES,2011,77(6):1054-1057.
APA An, Shu-Chang,Xu, Li-Li,Li, Feng-Di,Bao, Lin-Lin,Qin, Chuan,&Gao, Zhan-Cheng.(2011).Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic.MEDICAL HYPOTHESES,77(6),1054-1057.
MLA An, Shu-Chang,et al."Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic".MEDICAL HYPOTHESES 77.6(2011):1054-1057.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[An, Shu-Chang]的文章
[Xu, Li-Li]的文章
[Li, Feng-Di]的文章
百度学术
百度学术中相似的文章
[An, Shu-Chang]的文章
[Xu, Li-Li]的文章
[Li, Feng-Di]的文章
必应学术
必应学术中相似的文章
[An, Shu-Chang]的文章
[Xu, Li-Li]的文章
[Li, Feng-Di]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。